Metagenomics Market by Product (Instrument & Software and Consumable), Technology (Sequencing and Bioinformatics), and Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, and Agriculture) - Global Opportunity Analysis and Industry Forecast, 2017-2024

Metagenomics Market 

The global metagenomics market was valued at USD 176 Million in 2017 and is expected to reach USD 523 Million by 2024 at a CAGR of 16.8% from 2018 to 2024.Metagenomics is the study of genomes collectively in a microbial community. This process involves cloning and analyzing the genomes without culturing the organisms in the community.

Metagenomics Market Trends

Increase in advancements regarding DNA sequencing and rise in expansion of metagenomics applications drive the growth of the global metagenomics market. However, dearth of skilled professionals coupled with the rise in concerns regarding standardization and accuracy of sequencing based diagnostic testing hampers the market growth. Moreover, developing nations offer profitable opportunities for metagenomic sequencing product manufacturers.

 

The global metagenomics market is segmented based on technology, product, application, and region. Based on technology, the market is bifurcated into sequencing and bioinformatics. By product, the market is divided into instrument & software and consumable. On the basis of application, the market is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. As per region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

 

Based on product, the global metagenomics market is categorized into instrument & software and consumable. The consumable segment accounted for a major share in the global market in 2017 and is expected to maintain this dominance throughout the forecast period. High adoption of consumables in the pre-sequencing, which is one of the most important steps in the overall metagenomic sequencing protocol, has contributed to the dominant position of this segment in the market. In addition, maximum utilization of consumables ensures that the DNA involved in the metagenomic analysis would be a representative of all cells in the sample and ideal for generation of genomic libraries. Whereas, the instrument & software segment is expected to register the highest growth rate during 2018-2024, owing to the continuous evolution in the development of software packages and instruments utilized in the metagenomic studies.

Application Segment Review

Based on application, the global metagenomics market is segmented into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. The gut microbe characterization segment  dominated the global market in 2017 and is expected to maintain this dominance throughout the forecast period. The human intestinal microbiota is a homeostatic ecosystem, which has a significant impact on human health, and the disruption of this equilibrium leads to increased susceptibility to infections by various pathogens. In addition, the application of metagenomics has aided in identifying bacterial pathogens such as Shiga Toxin-producing E. coli (STEC) infection, which is associated with foodborne disease outbreaks. Whereas, the infectious disease diagnosis segment is expected to grow at the fastest pace during the forecast period. This is attributed to the increasing popularity of metagenomic technologies among clinical researchers, which aids in identification of responsible bacterial pathogens in several infectious diseases.

Geography Segment Review 

Region-wise, the global metagenomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the major contributor in terms of revenue in 2017 and is anticipated to maintain this dominance throughout the forecast period. This is attributed to the increasing implementation of DNA sequencing across metagenomic applications in this region. In addition, rapid adoption of novel sequencing technologies in this region has contributed to its dominance. Whereas, the Asia-Pacific region is estimated to register the highest CAGR during the forecast period, owing to the considerable patient population base along with the continuously evolving healthcare infrastructure across countries in this region.

The report provides a comprehensive analysis of the key players operating in the global metagenomics market, such as Agilent Technologies, Inc., Enterome SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Qiagen N.V., Swift Biosciences, Inc., and Thermo Fisher Scientific, Inc. The other players operating in the global metagenomics market include Siemens AG, ZS Genetics, Inc., Abbott Laboratories, Beckman Coulter, LI-COR, Genomatix GmbH, Beijing Genomics Institute, and Pieriandx.

By Type 

• Instrument & software
• Consumable

By Product

• Sequencing
• Bioinformatics

By Application

• Infectious disease diagnosis
• Environmental remediation
• Gut microbe characterization
• Biotechnology
• Biofuel
• Agriculture

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Taiwan
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• Rest of LAMEA

By Company

• Agilent Technologies, Inc.
• Enterome SA
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Qiagen N.V.
• Swift Biosciences, Inc.
• Thermo Fisher Scientific, Inc.

The other players in the value chain include (profiles not included in the report): 

• Siemens AG
• ZS Genetics, Inc.
• Abbott Laboratories
• Beckman Coulter
• LI-COR
• Genomatix GmbH
• Beijing Genomics Institute
• Pieriandx

TABLE OF CONTENT

LIST OF TABLES & FIGURES